← Company directoryNASDAQ · SEC EDGAR
NovoCure Limited
NVCRA primary-source company identity page built for fast discovery, filing verification and consistent financial research.
SHARE PRICE · INDICATIVE——
A recent price could not be verified. Check the exchange before trading.
ANALYSIS ROUTE
Four checks before any decision
Business model
Understand how the company earns and where demand originates.
Revenue and margin
Compare equivalent periods; separate growth from profitability.
Debt and cash flow
Test balance-sheet resilience and cash conversion.
Valuation and risk
Use sector peers, scenarios and explicit risk limits.
Dates connected to this company
Confirmed events from the FinRatex financial calendar, linked to their named sources.
Novocure third-quarter 2026 results
Novocure will report third-quarter results before the U.S. financial markets open on October 29. The company did not announce an exact release time; the call begins that day at 3:00 PM Istanbul.
Novocure ↗Novocure Q3 earnings call
Novocure management will discuss third-quarter results on October 29 at 8:00 AM EDT / 3:00 PM Istanbul. Results are due before the U.S. financial markets open that day.
Novocure ↗More NASDAQ records
Alphabetically adjacent directory records for faster navigation; this is not a peer or valuation classification.
DATA STATUS
Open official filings ↗Checking SEC financial statements
A dash means standardized data is unavailable. Always check the filing period, currency and accounting scope.